Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Serine Protease
    (4)
  • SARS-CoV
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Cardiovascular System
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Respiratory System
    (1)
Filter
Search Result
Results for "

mouse neutrophil elastase

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • FK706
    T15285144055-55-0
    FK706 is a slow-binding and competitive human neutrophil elastase inhibitor (IC50: 83 nM; Ki: 4.2 nM). FK706 also inhibits mouse neutrophil elastase and porcine pancreatic elastase (IC50s: 22 nM and 100 nM, respectively). FK706 has an anti-inflammatory ef
    • $1,530
    8-10 weeks
    Size
    QTY
  • SSR 69071
    T21989344930-95-6In house
    SSR69071 is a potent, orally active, and selective inhibitor of neutrophil elastase, displaying higher affinity for human elastase (Ki = 0.0168 nM) compared to rat (Ki = 3 nM), mouse (Ki = 1.8 nM), and rabbit (Ki = 58 nM) elastases [2]. It reduces myocardial infarct size following ischemia-reperfusion injury [1] and has potential for treating chronic obstructive pulmonary diseases, asthma, emphysema, cystic fibrosis, and various inflammatory diseases.
    • $113
    35 days
    Size
    QTY
  • Sivelestat sodium
    ONO5046 sodium, ONO 5046 sodium, LY-544349 sodium, LY544349 sodium, EI546 sodium, EI 546 sodium
    T21414150374-95-1
    Sivelestat sodium (EI 546 sodium) is a highly efficient inhibitor of human neutrophil elastase, improving sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway. It can be used in acute lung injury/acute respiratory distress syndrome research.
    • $30
    In Stock
    Size
    QTY
  • AX-9657
    T2146331015439-77-6
    KRP-109 is a neutrophil elastase (NE) inhibitor known for its ability to alleviate lung inflammation. In mouse models, KRP-109 has been shown to increase survival rates and reduce both the number of neutrophils in alveolar walls and the severity of inflammation. It significantly decreases cell and neutrophil counts, along with cytokine levels (such as interleukin 1β and macrophage inflammatory protein 2) in bronchoalveolar lavage fluid. KRP-109 is applicable for investigating severe pneumonia.
    • Inquiry Price
    10-14 weeks
    Size
    QTY